- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Medicity Unveils Security Product For Medical Customers
Internet platform provider Medicity is making its MediTrust security program available as a stand-alone product for healthcare customers. Integrated into the Medicity Internet platform, MediTrust was designed to create a secure environment in which
Internet platform provider Medicity is making its MediTrust security program available as a stand-alone product for healthcare customers. Integrated into the Medicity Internet platform, MediTrust was designed to create a secure environment in which physicians, hospitals, practice groups, and labs can exchange patient records and other sensitive data. It allows a user to establish a secure connection from any computer with access to the Internet, including personal digital assistants (PDAs). The Medicity platform is designed to give physicians an Internet desktop, accessible via a single login, that ties together all of the electronic resources specific to their practice, including lab data, office communications, third-party ASP offerings, and practice-specific content.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
